These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 434904)

  • 21. Theophylline pharmacokinetics in premature infants with apnea.
    Giacoia G; Jusko WJ; Menke J; Koup JR
    J Pediatr; 1976 Nov; 89(5):829-32. PubMed ID: 789845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sleep and aminophylline treatment of apnea in preterm infants.
    Gabriel M; Witolla C; Albani M
    Eur J Pediatr; 1978 Jul; 128(3):145-9. PubMed ID: 668722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data.
    Jamali F; Barrington KJ; Finer NN; Coutts RT; Torok-Both GA
    Dev Pharmacol Ther; 1988; 11(5):253-7. PubMed ID: 3191816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of theophylline in preterm neonates during the first month of life.
    Islam SI; Ali AS; Sheikh AA; Fida NM
    Saudi Med J; 2004 Apr; 25(4):459-65. PubMed ID: 15083216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
    Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
    Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in state in apneic pre-term infants receiving theophylline.
    Dietrich J; Krauss AN; Reidenberg M; Drayer DE; Auld PA
    Clin Pharmacol Ther; 1978 Oct; 24(4):474-8. PubMed ID: 688737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in plasma nonesterified fatty acids and blood glucose in the newborn infant in therapy with aminophylline].
    Zanardo V; Benini F; Pesenti P; Ronconi M; Furlanut M
    Pediatr Med Chir; 1984; 6(2):253-5. PubMed ID: 6531248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apnoea, bradycardia, and oxygen saturation in preterm infants.
    Upton CJ; Milner AD; Stokes GM
    Arch Dis Child; 1991 Apr; 66(4 Spec No):381-5. PubMed ID: 2025028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The xanthine treatment of apnea of prematurity.
    Lucey JF
    Pediatrics; 1975 May; 55(5):584-6. PubMed ID: 1128983
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative Study of the Efficacy and Safety of Caffeine and Aminophylline for the Treatment of Apnea in Preterm Infants].
    Nagasato A; Nakamura M; Kamimura H
    Yakugaku Zasshi; 2018; 138(2):237-242. PubMed ID: 29386437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rectal aminophylline gel in treatment of apnoea in premature newborn babies.
    Cooney S; Dhillon S; Bennett G; Trehane C
    Lancet; 1991 Jun; 337(8753):1351. PubMed ID: 1674328
    [No Abstract]   [Full Text] [Related]  

  • 33. Erythropoietin levels during theophylline treatment in premature infants.
    Gonzalez MT; Sherwood JB; Brion LP; Schulman M
    J Pediatr; 1994 Jan; 124(1):128-30. PubMed ID: 8283362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac output changes secondary to theophylline therapy in preterm infants.
    Walther FJ; Sims ME; Siassi B; Wu PY
    J Pediatr; 1986 Nov; 109(5):874-6. PubMed ID: 3772667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic aspects of theophylline in premature newborns.
    Aranda JV; Sitar DS; Parsons WD; Loughnan PM; Neims AH
    N Engl J Med; 1976 Aug; 295(8):413-6. PubMed ID: 934239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of apnea of prematurity with aminophylline.
    Bednarek FJ; Roloff DW
    Pediatrics; 1976 Sep; 58(3):335-9. PubMed ID: 958760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of two dosing equations for theophylline in premature infants.
    Bhatt-Mehta V; Donn SM; Schork MA; Reed S; Johnson CE
    Pharmacotherapy; 1996; 16(5):769-76. PubMed ID: 8888073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma concentration-effect relationship of theophylline in treatment of apnea in preterm infants.
    Lagercrantz H; Rane A; Tunell R
    Eur J Clin Pharmacol; 1980 Jul; 18(1):65-8. PubMed ID: 7398750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity.
    Tay-Uyboco J; Kwiatkowski K; Cates DB; Seifert B; Hasan SU; Rigatto H
    Biol Neonate; 1991; 59(4):190-200. PubMed ID: 2070020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential treatment of theophylline toxicity by high surface area activated charcoal.
    Ginoza GW; Strauss AA; Iskra MK; Modanlou HD
    J Pediatr; 1987 Jul; 111(1):140-2. PubMed ID: 3598776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.